CTI BioPharma (FRA:CEPS) Other Income (Expense) : €-0.04 Mil (TTM As of Mar. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Other Income (Expense)?

CTI BioPharma's other income expense for the CTI BioPharma's pretax income for the three months ended in Mar. 2023 was €-0.01 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.04 Mil.

CTI BioPharma Other Income (Expense) Historical Data

The historical data trend for CTI BioPharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Other Income (Expense) Chart

CTI BioPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Income (Expense)

Get a 7-Day Free Trial

2.99

0.22

-3.17

-0.14

-0.05

CTI BioPharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Other Income (Expense)	Get a 7-Day Free Trial															-0.01	-0.01	0.08	-0.10	-0.01

CTI BioPharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

CTI BioPharma (FRA:CEPS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

CTI BioPharma (FRA:CEPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121

Website

https://www.ctibiopharma.com

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines